134 related articles for article (PubMed ID: 23792545)
1. Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticles.
Rudzka K; Viota JL; Muñoz-Gamez JA; Carazo A; Ruiz-Extremera A; Delgado ÁV
Colloids Surf B Biointerfaces; 2013 Nov; 111():88-96. PubMed ID: 23792545
[TBL] [Abstract][Full Text] [Related]
2. Maghemite functionalization for antitumor drug vehiculization.
Rudzka K; Delgado AV; Viota JL
Mol Pharm; 2012 Jul; 9(7):2017-28. PubMed ID: 22694673
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
6. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
[TBL] [Abstract][Full Text] [Related]
7. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
8. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
10. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
[TBL] [Abstract][Full Text] [Related]
12. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release.
Basuki JS; Duong HT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP
ACS Nano; 2013 Nov; 7(11):10175-89. PubMed ID: 24131276
[TBL] [Abstract][Full Text] [Related]
13. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional magnetic silica nanotubes for MR imaging and targeted drug delivery.
Huang L; Ao L; Wang W; Hu D; Sheng Z; Su W
Chem Commun (Camb); 2015 Mar; 51(18):3923-6. PubMed ID: 25656155
[TBL] [Abstract][Full Text] [Related]
15. In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging.
Li WM; Chen SY; Liu DM
Acta Biomater; 2013 Feb; 9(2):5360-8. PubMed ID: 23022876
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
19. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
[TBL] [Abstract][Full Text] [Related]
20. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
